Article date: January 1987
By: CM Dixon, RW Fuller, PJ Barnes, in Volume 23, Issue 1, pages 91-93
The effect of a potent inhibitor of angiotensin‐converting enzyme, ramipril, was studied on both inhaled histamine and bradykinin‐induced bronchoconstriction in six male, normotensive, mild asthmatic subjects. Oral administration of 10 mg ramipril caused no change in lung function or airway reactivity to inhaled histamine or bradykinin despite achieving adequate reduction in angiotensin‐converting enzyme activity.
DOI: 10.1111/j.1365-2125.1987.tb03015.x
View this article